jason_flowerday_emba
2004
Jason Flowerday (EMBA) has sold his specialty pharmaceutical company, Orphan Canada, to Knight Therapeutics (TSX:GUD), where he is now Vice President, Commercial Operations, and a member of Knight’s leadership team. This follows Jason’s sale of RxMedia Healthcare Communications in 2012. A bit of extra free time at that point allowed Jason to complete his second (“and likely last!” he says) Ironman triathlon, at Mont Tremblant, Que. in Aug. 2013.